Martin Fan
Stock Analyst at Wedbush
(4.87)
# 68
Out of 5,147 analysts
19
Total ratings
77.78%
Success rate
61.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZURA Zura Bio | Initiates: Outperform | $15 | $6.62 | +126.59% | 1 | Feb 9, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Outperform | $42 → $45 | $34.41 | +30.78% | 2 | Jan 13, 2026 | |
| ZBIO Zenas BioPharma | Reiterates: Outperform | $45 | $26.35 | +70.78% | 3 | Dec 22, 2025 | |
| VOR Vor Biopharma | Assumes: Neutral | $9 | $15.44 | -41.71% | 1 | Nov 25, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $6.72 | -70.24% | 1 | Nov 25, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $50 | $55.05 | -9.17% | 5 | Nov 24, 2025 | |
| SANA Sana Biotechnology | Maintains: Outperform | $5 → $6 | $4.21 | +42.52% | 2 | Nov 7, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Outperform | $18 → $23 | $5.82 | +295.19% | 2 | Oct 17, 2025 | |
| RNAC Cartesian Therapeutics | Initiates: Outperform | $38 | $7.59 | +400.66% | 1 | Jul 9, 2025 | |
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $2.87 | +178.75% | 1 | May 28, 2025 |
Zura Bio
Feb 9, 2026
Initiates: Outperform
Price Target: $15
Current: $6.62
Upside: +126.59%
Oruka Therapeutics
Jan 13, 2026
Maintains: Outperform
Price Target: $42 → $45
Current: $34.41
Upside: +30.78%
Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $26.35
Upside: +70.78%
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $15.44
Upside: -41.71%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.72
Upside: -70.24%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $55.05
Upside: -9.17%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5 → $6
Current: $4.21
Upside: +42.52%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $5.82
Upside: +295.19%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $7.59
Upside: +400.66%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $2.87
Upside: +178.75%